Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus...

Area of Science:

• Infectious Diseases
• Hospital Epidemiology
• Antimicrobial Stewardship

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in healthcare settings.
• Guidelines recommend reducing fluoroquinolone use where MRSA is prevalent.
• The impact of fluoroquinolone restriction on MRSA infection rates requires evaluation.

Purpose of the Study:

• To assess if limiting fluoroquinolone antibiotic use reduces nosocomial MRSA infections.
• To analyze changes in overall antibiotic consumption.
• To identify other factors associated with MRSA infection rates.

Main Methods:

• A single-center, quasi-experimental design was employed.
• Monthly nosocomial MRSA infection rates were tracked over three years (July 2001-June 2004).
• Segmented regression analysis evaluated correlations between infection rates and various factors, including a physician-directed intervention to limit fluoroquinolones.

Main Results:

• Fluoroquinolone use decreased by 34% post-intervention, with a 50% reduction in levofloxacin.
• Nosocomial MRSA infection rates significantly decreased from 1.37 to 0.63 per 1,000 patient-days (P=.02).
• MRSA infection rates correlated positively with levofloxacin and azithromycin use, and negatively with the intervention and summer season.

Conclusions:

• Limiting institutional fluoroquinolone use appears associated with reduced nosocomial MRSA infection rates.
• The findings support antimicrobial stewardship strategies targeting fluoroquinolone prescribing.
• Further research may explore the broader impact on other pathogens and resistance patterns.